$RSLS
ReShape Lifesciences Inc.

2024 Q4 Form 10-Q Financial Statement

#000155837024015732 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $2.292M
YoY Change 6.36%
Cost Of Revenue $853.0K
YoY Change -1.61%
Gross Profit $1.439M
YoY Change 11.72%
Gross Profit Margin 62.78%
Selling, General & Admin $719.0K
YoY Change -59.85%
% of Gross Profit 49.97%
Research & Development $399.0K
YoY Change -26.38%
% of Gross Profit 27.73%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.200M
YoY Change -38.08%
Operating Profit -$1.761M
YoY Change -54.61%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $109.0K
YoY Change
Pretax Income -$1.575M
YoY Change -55.4%
Income Tax $6.000K
% Of Pretax Income
Net Earnings -$1.581M
YoY Change -55.26%
Net Earnings / Revenue -68.98%
Basic Earnings Per Share -$3.11
Diluted Earnings Per Share -$3.11
COMMON SHARES
Basic Shares Outstanding 712.7K 29.39M
Diluted Shares Outstanding 508.9K

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $743.0K
Short-Term Investments
Other Short-Term Assets $51.00K
YoY Change -45.74%
Inventory $2.934M
Prepaid Expenses
Receivables $1.300M
Other Receivables
Total Short-Term Assets $5.338M
YoY Change -27.86%
LONG-TERM ASSETS
Property, Plant & Equipment $43.00K
YoY Change -38.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $29.00K
YoY Change 0.0%
Total Long-Term Assets $277.0K
YoY Change -35.28%
TOTAL ASSETS
Total Short-Term Assets $5.338M
Total Long-Term Assets $277.0K
Total Assets $5.615M
YoY Change -28.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.105M
YoY Change 43.98%
Accrued Expenses $1.643M
YoY Change -39.9%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.025M
YoY Change -9.94%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.025M
Total Long-Term Liabilities
Total Liabilities $4.128M
YoY Change -12.98%
SHAREHOLDERS EQUITY
Retained Earnings -$640.9M
YoY Change 1.11%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.487M
YoY Change
Total Liabilities & Shareholders Equity $5.615M
YoY Change -28.26%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.581M
YoY Change -55.26%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001427570
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.017
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-37897
dei Entity Registrant Name
EntityRegistrantName
RESHAPE LIFESCIENCES INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1828101
dei Entity Address Address Line1
EntityAddressAddressLine1
18 Technology Dr, Suite 110
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
429-6680
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
RSLS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
712680
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
743000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4459000
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
100000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
100000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
866000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
804000
CY2024Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1344000
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1659000
CY2024Q3 us-gaap Inventory Net
InventoryNet
2934000
CY2023Q4 us-gaap Inventory Net
InventoryNet
3741000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
217000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
337000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
5338000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
10296000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
177000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
250000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
28000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
28000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29000
CY2024Q3 us-gaap Assets
Assets
5615000
CY2023Q4 us-gaap Assets
Assets
10663000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2105000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1689000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1643000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1814000
CY2024Q3 rsls Warrant Liability Current
WarrantLiabilityCurrent
163000
CY2023Q4 rsls Warrant Liability Current
WarrantLiabilityCurrent
163000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
114000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
111000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4025000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3777000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
77000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
151000
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
26000
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
72000
CY2024Q3 us-gaap Liabilities
Liabilities
4128000
CY2023Q4 us-gaap Liabilities
Liabilities
4000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
704697
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
704697
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
404437
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
404437
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
642518000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
642325000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-640943000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-635574000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-88000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-88000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1487000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6663000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5615000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10663000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2292000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2155000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6201000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6696000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
853000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
867000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2463000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2990000
CY2024Q3 us-gaap Gross Profit
GrossProfit
1439000
CY2023Q3 us-gaap Gross Profit
GrossProfit
1288000
us-gaap Gross Profit
GrossProfit
3738000
us-gaap Gross Profit
GrossProfit
3706000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
719000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1791000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2408000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6150000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2082000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2058000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6074000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8724000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
399000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
542000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1282000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1576000
CY2023Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
777000
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
777000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
33000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
3200000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
5168000
us-gaap Operating Expenses
OperatingExpenses
9764000
us-gaap Operating Expenses
OperatingExpenses
17194000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1761000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3880000
us-gaap Operating Income Loss
OperatingIncomeLoss
-6026000
us-gaap Operating Income Loss
OperatingIncomeLoss
-13488000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
13000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
9000
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-27000
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-412000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-46000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3850000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
429000
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
50000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-68000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
10000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-47000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
109000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
193000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1575000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3531000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5335000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9668000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1581000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3534000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5369000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9689000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.11
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.11
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-59.36
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-59.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.94
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-199.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-199.98
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
508851
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
508851
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59538
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59538
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
449614
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
449614
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48451
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48451
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1581000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3534000
us-gaap Net Income Loss
NetIncomeLoss
-5369000
us-gaap Net Income Loss
NetIncomeLoss
-9689000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1580000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3533000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5369000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9695000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
3035000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1581000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1487000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6663000
us-gaap Net Income Loss
NetIncomeLoss
-5369000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
169000
rsls Stock And Warrants Issued During Period Value Institutional Exercise Of Warrants
StockAndWarrantsIssuedDuringPeriodValueInstitutionalExerciseOfWarrants
24000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1487000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6738000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3534000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
216000
CY2023Q3 rsls Adjustments To Additional Paid In Capital Stock Offering Costs
AdjustmentsToAdditionalPaidInCapitalStockOfferingCosts
-338000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3083000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3661000
us-gaap Net Income Loss
NetIncomeLoss
-9689000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
656000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
895000
rsls Adjustments To Additional Paid In Capital Stock Offering Costs
AdjustmentsToAdditionalPaidInCapitalStockOfferingCosts
-247000
rsls Stock And Warrants Issued During Period Value Institutional Exercise Of Warrants
StockAndWarrantsIssuedDuringPeriodValueInstitutionalExerciseOfWarrants
7813000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3083000
us-gaap Profit Loss
ProfitLoss
-5369000
us-gaap Profit Loss
ProfitLoss
-9689000
us-gaap Depreciation
Depreciation
17000
us-gaap Depreciation
Depreciation
114000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33000
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
777000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
429000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
33000
us-gaap Share Based Compensation
ShareBasedCompensation
169000
us-gaap Share Based Compensation
ShareBasedCompensation
656000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
61000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
450000
us-gaap Inventory Write Down
InventoryWriteDown
140000
us-gaap Inventory Write Down
InventoryWriteDown
101000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-46000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3850000
rsls Offering Cost
OfferingCost
298000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-12000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-256000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
422000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-667000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-307000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-119000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
329000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
673000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2764000
rsls Increase Decrease In Warrant Liability
IncreaseDecreaseInWarrantLiability
-182000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-17000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3740000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14503000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
43000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
33000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12451000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
24000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
338000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12113000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-6000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3716000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2406000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4559000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3955000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
843000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1549000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:27pt;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may materially differ from these estimates. The Company reviews its estimates on an ongoing basis or as new information becomes available to ensure that these estimates appropriately reflect changes in its business.</p>
CY2024Q3 rsls Working Capital
WorkingCapital
1300000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
800000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1300000
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
965000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1020000
CY2024Q3 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
1163000
CY2023Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
1379000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
806000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1342000
CY2024Q3 us-gaap Inventory Net
InventoryNet
2934000
CY2023Q4 us-gaap Inventory Net
InventoryNet
3741000
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
95000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
110000
CY2024Q3 rsls Prepaid Professional Services
PrepaidProfessionalServices
29000
CY2024Q3 rsls Prepaid Patent Expense Current
PrepaidPatentExpenseCurrent
5000
CY2023Q4 rsls Prepaid Patent Expense Current
PrepaidPatentExpenseCurrent
13000
CY2024Q3 us-gaap Prepaid Advertising
PrepaidAdvertising
21000
CY2023Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
41000
CY2024Q3 us-gaap Prepaid Taxes
PrepaidTaxes
16000
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
47000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
51000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
126000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
217000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
337000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
702000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
701000
CY2023Q4 rsls Accrued Legal Liabilities Current
AccruedLegalLiabilitiesCurrent
200000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
683000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
639000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
44000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
61000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
169000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
155000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
45000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
58000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1643000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1814000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
429000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
100000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
16000
us-gaap Operating Lease Cost
OperatingLeaseCost
100000
us-gaap Operating Lease Cost
OperatingLeaseCost
300000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
177000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
250000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
114000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
111000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
77000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
151000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
191000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
262000
us-gaap Operating Lease Payments
OperatingLeasePayments
83000
us-gaap Operating Lease Payments
OperatingLeasePayments
174000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
28000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
115000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
59000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
202000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
191000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.069
CY2024Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
24000
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10200000
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
268937
rsls Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
187415
rsls Class Of Warrant Or Right Cancelled In Period
ClassOfWarrantOrRightCancelledInPeriod
90
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
81432
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2292000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2155000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6201000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6696000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
216000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
169000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
656000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y18D
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-015732-index-headers.html Edgar Link pending
0001558370-24-015732-index.html Edgar Link pending
0001558370-24-015732.txt Edgar Link pending
0001558370-24-015732-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rsls-20240930.xsd Edgar Link pending
rsls-20240930x10q.htm Edgar Link pending
rsls-20240930xex31d1.htm Edgar Link pending
rsls-20240930xex31d2.htm Edgar Link pending
rsls-20240930xex32d1.htm Edgar Link pending
rsls-20240930xex32d2.htm Edgar Link pending
Show.js Edgar Link pending
rsls-20240930_def.xml Edgar Link unprocessable
rsls-20240930_pre.xml Edgar Link unprocessable
rsls-20240930_lab.xml Edgar Link unprocessable
rsls-20240930x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
rsls-20240930_cal.xml Edgar Link unprocessable